CLASS III Drug recall · Reported 6 Nov 2019 · FDA Enforcement Report
PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg recalled
Nephron Pharmaceuticals is recalling PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg, distributed nationwide in the US. The recall was initiated on 21 Oct 2019 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0154-2020
- FDA event ID
- 84106
- Recalling firm
- Nephron Pharmaceuticals, West Columbia, SC
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 21 Oct 2019
- FDA classified
- 28 Oct 2019
- Reported
- 6 Nov 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Labeling Errors
- Drug class
- Injectable & IV Drugs
Timeline
| 21 Oct 2019 | Recall initiated by company | |
| 28 Oct 2019 | Classified by FDA | +7 days |
| 6 Nov 2019 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Incorrect labeling: Incorrect or missing lot and/or exp date
Product as listed by the FDA
PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.
Where it was distributed
Nationwide in the U.S.
Questions about this recall
Why was it recalled?
Incorrect labeling: Incorrect or missing lot and/or exp date
Which lots are affected?
Lots: SU9079A, SU9079B, Exp 4/5/2020
Where was it sold?
Nationwide in the U.S.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Nephron Pharmaceuticals
All 16| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl recalled | Nephron Pharmaceuticals | Foreign Material | Nationwide |
| Drug | CLASS II | del Nido Cardioplegia Solution, Single-Dose Container recalled | Nephron Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl recalled | Nephron Pharmaceuticals | Foreign Material | Nationwide |
| Drug | CLASS II | PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl recalled | Nephron Pharmaceuticals | Foreign Material | Nationwide |
| Drug | CLASS II | Amino Acid Injection (50 mg/mL) L-Arginine HCl recalled | Nephron Pharmaceuticals | Sterility | Nationwide |